No description available.

Oral squamous cell carcinoma (OSCC) accounts for majority of head and neck cancers and ranks as the sixth most common cancer in the world. OSCC belongs to the most understudied cancers and little is known about molecular mechanisms underlying its etiology and progression to metastasis. A hallmark of cancer is the enhanced posttranslational modification of cell surface proteins with complex N-glycans. Our studies have shown that induced protein N-glycosylation via activation of the core N-glycosylation-regulating gene, DPAGT1, is associated with reduced E-cadherin adhesion, as well as deregulation of several oncogenic signaling pathways, including Wnt/β-catenin and Hippo. Modest increases in DPAGT1 expression are associated with dramatic amplification of Wnt/β-catenin activity and increased expression and nuclear localization of the Hippo pathway effectors TAZ /YAP. The goal of this study was to align the expression and localization of DPAGT1, complex N-glycans, β-catenin, and TAZ/YAP with the progression of oral cancer in vivo from dysplasia to OSCC. Human oral tissues from different stages of OSCC pathogenesis were characterized for DPAGT1/β-catenin/α-catenin/YAP/TAZ expression and localization and correlated with cell surface expression of complex N-glycans by PHA lectin staining and with expression of primitive cell surface markers, CD44, CD24 and CD29. Results showed that high DPAGT1 expression and nuclear TAZ became increasingly associated with disorganized E-cadherin junctions as oral epithelium progressed from mild to severe dysplasia to OSCC. This correlated with increasing expression of cell surface complex N-glycans and CD44. These studies suggest that DPAGT1/β-catenin/TAZ and high PHA staining represent novel signatures for OSCC pathogenesis.

Das primäre Offenwinkelglaukom (POWG) ist eine mit typischen Gesichtfeld- und Papillenschäden einhergehende Erkrankung des Auges, die in den westlichen Industrienationen zu den häufigsten Erblindungsursachen zählt. An Glaukom erkrankte Patienten weisen häufig erhöhte Augeninnendruckwerte und gesteigerte TGF-beta 2-Spiegel im Kammerwasser auf. Der Augeninnendruck wird im Wesentlichen durch den Abflusswiderstand des Trabekelmaschenwerks bestimmt. In der vorliegenden Arbeit wurde der Einfluss des Wachstumsfaktors TGF-beta 2 auf das Zytoskelett von menschlichen Trabekelmaschenwerkszellen (HTM) untersucht. Hierbei konnten die bereits bekannten TGF-beta-Effekte, nämlich verstärkte Stressfaserbildung und Zunahme der alpha-SMA- sowie Aktin-Expression bestätigt werden. Bisher unbekannt war die Zunahme der Expression von N-Cadherin und beta-Catenin unter TGF-beta, die Veränderungen der Zell-Zell-Adhäsionen nach sich zieht und damit auch Einfluss auf die biomechanischen Eigenschaften des Trabekelmaschenwerks haben könnte. beta-Catenin ist hierbei auch unter dem Einfluss von TGF-beta nur zu einem geringen Anteil im Zellkern lokalisiert, was mit einer vermehrten Lokalisation von beta-Catenin in Zell-Zell-Verbindungen vereinbar ist. Da vermutlich unter TGF-beta-Stimulation sogar eher weniger beta-Catenin als Mediator für den Wnt-Signalpfad zur Verfügung steht, könnte ein TGF-beta-vermittelter Wnt-Antagonismus eine Rolle in der Entstehung des POWG spielen. Es ist bekannt dass eine Hemmung des Wnt-Signalwegs den Augeninnendruck erhöht. Im Rahmen dieser Arbeit konnte gezeigt werden, dass an der TGF-beta 2-Signalgebung in humanen Trabekelmaschenwerkszellen außer dem klassischen Smad-Weg auch MEK/ERK und PI3K/AKT an der Signalübertragung beteiligt sind. Hierbei sind die TGF-beta-induzierten Änderungen der Zell-Zell-Verbindungen von der Smad- und AKT-Signalgebung abhängig, während die Effekte von TGF-beta auf alpha-SMA über den MEK/ERK-Signalweg vermittelt werden. Die Ergebnisse der vorliegenden Arbeit zeigen einige neu beobachtete TGF-beta-Effekte im Trabekelmaschenwerk, von denen insbesondere die Veränderungen des Zellskeletts und der Zell-Zell-Verbindungen sowie die möglicherweise stattfindende Depletion des Wnt-Signalweges Bedeutung für die Entstehung des Offenwinkelglaukoms haben könnten. / Primary open angle glaucoma (POAG) is a chronic optic neuropathy with elevated intraocular pressure and ageing as major risk factors. The incidence of POAG is expected to rise in the aging industrial societies. Structural changes in the trabecular meshwork (TM) and elevated TGF-beta 2 levels in the aequous humor have been described in POAG-patients. It has been shown that TGF-beta modulates the amount and the composition of the extracellular matrix and intracellular proteins in the TM. Here we show that TGF-beta 2 modulates the cytosceletal rearrangements and the expression of cadherins in human TM cells. These changes require the canonical Smad-pathway as well as non-canonical signaling by the Pi3K/AKT- and MEK/ERK-pathways. Changes in the cytoskeleton and cell-cell adhesions might influence the mechanotransduction characteristics of TM tissue and thus have effects on the regulation of intraocular pressure with implications in primary open angle glaucoma.

AB T mu hom dise β sign mu liga stab tran sign T the focu disc cate of t cell targ the inte con sec I sign BSTRACT The Wnt si lticellular o meostasis. A eases, most β-catenin is nalling). In ltiprotein c ands when t bilized and nscription f nalling is tig This thesis knowledge uses on seq cusses the enin signall the Wnt pa ls of intest geted mous thesis des eraction wit nditional Hi retory cell t In conclusi nalling path T ignalling pa organisms Accordingly notably can s a central m n unstimula complex and they engage d transloca factors and ghtly regula is based on e of the reg quential po positive ro ling outcom athway whic tinal epithe e strains th scribes unp th members ic1 deletion types and en ion, our fin hway in dev athway is o ensuring s y, mutations ncer. mediator of ated cells d degraded e their recep tes to the to drive th ated at vario n four origin gulation of sttranslation ole of nucle me. The third ch reduces lium. Final at enable st ublished da s of the Wn n in the inte nhanced tum ndings contr velopment an one of the m successful s in the pat f canonical W β-catenin d in the pro ptors, degrad nucleus t he transcrip ous levels b nal articles f the Wnt s nal process ear protein d study repo the levels o lly, the las tudying the ata on the nt pathway, estinal epith mourigenesi ributed to t...

Tracheobronchial submucosal glands (SMGs) develop from clusters of epithelial progenitor cells basally orientated within the surface airway epithelium called primordial glandular placodes (PGPs). Signal transduction events that coordinate the transitional process from PGPs into fully developed SMGs consisting of intricately branched networks of tubular secretary structures are still poorly understood. Wnt/β-catenin dependent induction of lymphoid enhancing factor-1 (Lef-1) expression in PGP progenitor/stem cells is required for SMG formation and maturation in the airway. In an effort to better understand the regulatory mechanisms that control Lef-1 during airway SMG development, I have studied its transcriptional regulation. I discovered that Sox2 expression is predominantly confined to the surface airway epithelium (SAE) and is repressed as Lef-1 is induced within PGPs. Deletion of Sox2 in polarized primary airway epithelia significantly enhances Lef-1 mRNA expression. Consequently, my hypothesis is that Sox2 functions as a negative regulator of Lef-1 expression in the SAE. I demonstrated that Sox2 modulates the expression of Lef-1 both independent and dependent on Wnt/β-catenin signaling. I discovered that a Sox2-binding site located in the Wnt Responsive Element (WRE) region of the 2.5Kb Lef-1 promoter is required for Sox2-mediated inhibition of β-catenin-dependent Lef-1 promoter transcription. It is important to understand the biology of SMG development because SMGs are the major mucus-producing structures in the proximal airway and are important in regulating the innate immunity of the lung in response to various neural signals. SMG ducts have also been proposed as a potential protective niche for slowly cycling progenitor cells (SCPCs). Hence, aberrant SMG function is thought to aggravate the pathoprogression of lung disease. Cystic fibrosis (CF) is a disease caused by a defect in the gene that encodes a chloride ion channel called cystic fibrosis transmembrane conductance regulator (CFTR). The absence of CFTR in serous cells within SMG ducts contributes to defective airway secretion, which alters the microenvironment within SMGs. I hypothesized that the glandular SCPC niche may be dysfunctional in CF. I reported that the neural peptide, calcitonin gene-related peptide (CGRP) activates CFTR-dependent SMG secretions and that this signaling pathway is hyperactivated in CF human, pig, ferret, and mouse SMGs. CFTR-deficient mice failed to maintain glandular SCPCs following airway injury, suggesting that the glandular SCPC niche may be dysfunctional in CF. CGRP levels increase following airway injury and function as an injury-inducible mitogen that stimulates progenitor cell proliferation. However, components of the receptor for CGRP (RAMP1 and CLR) were expressed in a very small subset of SCPCs, suggesting that CGRP indirectly stimulates SCPC proliferation through paracrine mechanisms. This discovery may have important implications for injury/repair mechanisms in the CF airway.

Aiming to identify immune molecules with a novel function in cancer pathogenesis, we found the cluster of differentiation 177 (CD177), a known neutrophil antigen, expression to be positively correlated with relapse-free (RFS), metastasis-free (MFS) or overall survival (OS) in several solid cancers including those from breast, prostate, cervix, and lung. To study the role of CD177 in breast cancer, we generated a total body Cd177 knockout mouse. These mice had no profound phenotype at 3 - months of age or younger. The only phenotype found at this age was reduced peripheral neutrophil counts, but no difference in their ability to clear infections. Upon further analysis these mice developed an age dependent hyperproliferative mammary gland phenotype at 10 - months of age that was lost in mice 15 - months and older. Focusing on breast cancer, we found that CD177 is expressed in normal breast epithelial cells and is significantly reduced in invasive cancer. We found that CD177 suppresses breast cancer pathogenesis. To understand the mechanism behind CD177 mediated suppression of breast cancer, we performed mass spectrometry on the purified CD177 complex. Mass spectrometry and co-immunoprecipitation results revealed CD177 interacts with β-Catenin and glycolytic enzymes PFK, aldolase A, GAPDH and enolase-ɑ. Further studies revealed that mechanistically CD177 forms a complex with ECadherin and β-Catenin at adherens junctions. This physical interaction between CD177, E-Cadherin and β-Catenin prevents β-Catenin activation via the canonical WNT. We also found CD177 suppressed WNT/β-Catenin signaling independent of E-Cadherin with an unknown protein. Thus, we identified a novel protein complex involving CD177 and proteins from adherens junctions that can suppress cancer formation via inhibiting the WNT/β-Catenin signaling pathway, a key cellular biological process relevant to the oncogenesis of multiple cancer types and tissue development. The lack of WNT/β- Catenin signaling control explains how mice without CD177 develop hyperproliferation of mammary epithelium in the mouse mammary gland. Interestingly, this phenotype is lost with age, possibly due to a decrease in WNT/β-Catenin signaling resulting from a decrease in progesterone and estrogen. In addition to CD177’s role in the regulation of WNT/β-Catenin signaling we also identified that CD177 plays a role in cancer cell metabolism. Since metabolism plays a significant role in cancer and CD177 interacts with glycolytic enzymes, we sought to determine if CD177 plays a role in metabolism. CD177 appears to interact with glycolytic enzymes, PFK, aldolase A, GAPDH, and ɑ-enolase and ultimately suppresses their mRNA expression. Furthermore, we found novel localization of CD177 at the mitochondrion, thus providing a potential explanation as to how an extracellular membrane bound protein such as CD177 interacts with glycolytic enzymes. Metabolic analysis of CD177 expression on cancer cells revealed that CD177 leads to a decrease in glucose uptake and a slight decrease in basal glycolysis, but an increase in lactate concentration. Further metabolic profiling also revealed that CD177 expression results in a significant decrease in glycolytic capacity (ECAR). Expression of CD177 also resulted in a significant decrease in basal respiration, ATP production, maximal respiration, and spare capacity (OCR) as well as an increase in reactive oxygen species. These data reveal that CD177 plays a novel role in cancer cell metabolism.

Tgf-β, Wnt, and Fgf signaling pathways are required for many developmental processes. Here, I investigated the requirement of these signaling pathways during tail regeneration and limb development in the Mexican axolotl (Ambystoma mexicanum). Using small chemical inhibitors during tail regeneration, I found that the Tgf-β signaling pathway was required from 0-24 and 48-72 hours post tail amputation (hpa), the Wnt signaling pathway was required from 0-120 hpa, and the Fgf signaling pathway was required from 0-12hpa. Tgf-β1 was upregulated after amputation and thus may mediate Tgf-β signaling pathway during tail regeneration. Both Smad-mediated and non-Smad mediated Tgf-β signaling were activated as early as 1hpa. Smad-mediated Tgf-β signaling via activated pSmad2 and pSmad3, and via phosphorylated Erk and Akt. Two different Tgf-β signaling pathway inhibitors, SB505124 and Naringenin, differentially regulated pSmad2, pSmad3, p-Erk, and p-Akt, while SB505124 and Naringenin both inhibited tail regeneration; only SB505124 reduced cell proliferation. Wnt/β-Catenin signaling was increased and was enhanced by Wnt-C59. Disruption of the Wnt signaling pathway directly or indirectly activated Erk and Akt signaling. Disruption of the Fgf signaling pathway decreased p-Erk and increased p-Akt. All three signaling pathways affected cell proliferation and mitosis during tail regeneration. The Wnt pathway inhibitor Wnt-C59 prevented forelimb bud outgrowth. The critical window for Wnt signaling regulating forelimb bud outgrowth was approximately developmental stage 40-42. Wnt signaling ligand Wnt3a and tight junction protein Zo-1 were expressed in the epidermis of the forelimb bud and both were down-regulated by Wnt-C59. Moreover, both Wnt and Fgf signaling pathways affected cell proliferation and mitosis of mesodermal cells during forelimb bud outgrowth. Overall, my results show that Tgf-β, Wnt, and Fgf signaling pathways are required for axolotl tail regeneration. All three pathways affect Erk and Akt signaling and guide cell proliferation and mitosis. The Wnt signaling pathway is required for forelimb bud outgrowth, and it appears to regulate expression of Wnt3a and Zo1, and control cell proliferation and mitosis of mesodermal cells underlying the forelimb epidermis. These data enrich understanding of signaling network dynamics that underlie tissue regeneration and vertebrate limb development.

CD4+ and CD8+ T cells, the essential mediators of cellular immune responses, are produced in the thymus following sequential maturation stages. Hematopoietic progenitors first seed the thymus and make T cell lineage specification and commitment decisions within the CD4−CD8− double negative (DN) compartment. Thymocytes then mature to the CD4+CD8+ double positive (DP) stage, followed by vigorous negative and positive selection processes. The positively selected DP thymocytes first give rise to CD4+CD8lo intermediate (IM) cells which then differentiate into MHC class II-restricted CD4+ and MHC class I-restricted CD8+ T cells, a crucial decision known as CD4+ vs. CD8+ lineage choice. The lineage choice decision is influenced by the timing, intensity, and duration of signals derived from the TCR and cytokines, and recent studies have identified a number of transcriptional factors that intrinsically regulate this critical fate decision. Among these, Th-POK (encoded by Zbtb7b, called Thpok here for simplicity and consistency with the literature) is specifically required for CD4+ differentiation while Runx factors promote CD8+ T cell production and repress Cd4 in CD8+ lineage committed cells. Upregulation of Thpok is most evident in the CD4+8lo IM cells and is required to antagonize Runx3 activity and expression to promote CD4+ lineage commitment. Collectively, the Th-POK-Runx3 axis appears to be a critical convergence point in the CD4+ vs. CD8+ lineage choice. After committing to either CD4+ or CD8+ thymocytes, lineage-inappropriate genes are silenced to ensure the distinct identity and functional divergence between these two cell types. Repression of the Cd4 gene on CD8+ lineage committed cells is mediated by a ~430 bp silencer sequence in its first intron. Likewise, Thpok is repressed in CD8+ T cells by a ~560 bp sequence upstream of the Thpok exon 1a, and both Cd4 and Thpok silencers contain consensus binding motifs for Runx factors, which are necessary for CD8+ lineage commitment. T cell factor 1 (TCF-1) and lymphoid enhancer binding factor 1 (LEF-1) are members of the TCF-LEF family transcription factors and abundantly expressed in T lineage cells, and known to be necessary for the maturation of DN T cells to the DP stage. However, because germline deletion of TCF-1 and LEF-1 causes severe early T cell developmental block and embryonic lethality, respectively, their roles beyond the DP stage are unknown. In my thesis work, I overcame these obstacles by conditionally ablating both TCF-1 and LEF-1 in DP thymocytes using CD4-Cre. We observed impaired differentiation of CD4+ T cells from the bipotent DP precursors in the absence of TCF-1 and LEF-1. Mechanistically, TCF-1 promotes CD4+ T cell development by positively regulating the expression of Thpok. TCF-1 and LEF-1 deficiency also results in derepression of the CD4 co-receptor in CD8+ lineage committed cells. In CD8+ T cells, TCF-1 interacts with Runx3 to repress expression of Cd4. These findings not only broaden the spectra of TCF-LEF-mediated regulatory activities in late stages of T cell development, but also reveal new paradigms in T cell fate decision and identity maintenance.

Der Wnt Signalweg spielt eine entscheidende Rolle in der Embryogenese durch Steuerung der Proliferation, Apoptose, Differenzierung und der Festlegung der Körperachsen im frühen Embryo. Eine Fehlregulation des Signalwegs durch Mutationen in einem der Proteine und Gene dieser hochkomplexen Signalkaskade kann fatale Folgen haben, und ist ein erster Schritt auf dem Weg der Krebsentstehung. Dabei spielt das Protein β-Catenin eine Schlüsselrolle im kanonischen Zweig des Wnt Signalwegs. Durch Steuerung seiner Konzentration im Zytoplasma wird die Expression seiner direkten Zielgene reguliert, da β-Catenin im aktiven Signalweg als Co-Transkriptionsfaktor agiert. Durch Sichtbarmachung dieses Proteins durch fluoreszierende Reportergenkonstrukte kann der Aktivitätsstatus des Wnt Signalwegs in der Zelle beobachtet werden. Das ermöglicht zum einen genaue Analysen des Signalwegs, wie zum Beispiel das Studium des Zusammenspiels mit anderen Signalwegen. Vor allem aber erlaubt es die gezielte Suche nach Wnt-Signalwegs-modulierenden Substanzen als potentielle Wirkstoffe in der Krebsmedikamentenentwicklung. In der vorliegenden Arbeit wurden mehrere Reportergenkonstrukte für die stabile Transfektion von Zelllinien entwickelt und hinsichtlich eines möglichen Einsatzes sowohl in der Forschung, als auch in Wirkstoffscreenings validiert. Dies umfasst sowohl mehrere Reporter mit β-Catenin als Fusionsprotein, als auch Wnt-Promoter-regulierte eGFP-Reporter, die den Akitvitätsstatus des Wnt-Signalwegs anzeigen. Mit Hilfe dieser Reporter konnten Untersuchungen zur Wirkung des Wnt-Signalwegs auf die Morphologie von transfizierten und nicht-transfizierten MDCK-Zellen durchgeführt werden. Überdies wurde ein promotorregulierter eGFP-Reporter konstruiert, mit welchem transfizierte Zellen mit aktiviertem Wnt-Signalweg aus einem Zellpool gefischt werden können. Diese Methode ist sowohl für den Einsatz in kultivierten Zelllinien, als auch in der Diagnostik nach der Transfektion primärer Zellen geeignet. Auf Grundlage der neuen Zelllinien wurde weiterhin ein neuer Screeningansatz für potentielle Wnt-Signalwegsinhibitoren entwickelt, der auf dem Ausbleichen der Fluoreszenz in einem Well einer Multiwell-Kulturplatte beruht. / The Wnt signaling pathway plays a crucial role in embryogenesis because of its controlling of proliferation, apoptosis, differentiation and defining of the body axes. Mutations in one of the players of this complex pathway are leading to a deregulation, which have fatal consequences in the mentioned fields and are the first steps of a normal cell towards a cancer cell. β-catenin plays a key role in the canonical part of the pathway. Its concentration changes in the cytoplasm regulate the expression of the target genes: when its high concentration leads to a translocation into the nucleus, β-catenin acts as an activator of the transcription complex. By the use fluorescent reporters fused to this protein the activity state of the Wnt signaling pathway can be visualized. This allows the analysis of the pathway and its interaction with others or a specific screen for Wnt modulating substances as potential drugs in the drug development for cancer treatment. In the present doctoral thesis, several reporter constructs were established for transient and stable transfection of cell lines. They were validated regarding to a possible application in drug screening assays and their use for research. In detail this comprises constructs for tracking β-catenin within a living cell as a fusion protein as well as eGFP reporters which are promoter regulated for monitoring the Wnt signaling state. With the help of these reporters several studies were performed: An analysis of the involvement of the Wnt signaling pathway in morphologic changes in MDCK cells, transfected as well as wild-type, was carried out. Further, an eGFP reporter was shown to be able to fish Wnt active cells out of a pool of different cells after transfection. This approach may be applicable as well in cell research as in diagnostics. Based on the newly generated cell lines a novel careening assay approach was established: While bleaching transfected cells, potential Wnt inhibitors may be found and characterized in a screening assay.

Thesis (Ph. D. in Biological Sciences)--Vanderbilt University, Dec. 2007. / Title from title screen. Includes bibliographical references.